Skip to main content
Top
Published in: BMC Geriatrics 1/2022

Open Access 01-12-2022 | Research

Strong evidence for age as the single most dominant predictor of medically supervised driving test—mini mental status test outcomes provide only weak but significant moderate additional predictive value

Authors: Yannik Isler, Simon Schwab, Regula Wick, Stefan Lakämper

Published in: BMC Geriatrics | Issue 1/2022

Login to get access

Abstract

Background

With age, medical conditions impairing safe driving accumulate. Consequently, the risk of accidents increases. To mitigate this risk, Swiss law requires biannual assessments of the fitness to drive of elderly drivers. Drivers may prove their cognitive and physical capacity for safe driving in a medically supervised driving test (MSDT) when borderline cases, as indicated by low performance in a set of four cognitive tests, including e.g. the mini mental status test (MMST). Any prognostic, rather than indicative, relations for MSDT outcomes have neither been confirmed nor falsified so far. In order to avoid use of unsubstantiated rules of thumb, we here evaluate the predictive value for MSDT outcomes of the outcomes of the standard set of four cognitive tests, used in Swiss traffic medicine examinations.

Methods

We present descriptive information on age, gender and cognitive pretesting results of all MSDTs recorded in our case database from 2017 to 2019. Based on these retrospective cohort data, we used logistic regression to predict the binary outcome MSDT. An exploratory analysis used all available data (model 1). Based on the Akaike Information Criterion (AIC), we then established a model including variables age and MMST (model 2). To evaluate the predictive value of the four cognitive assessments, model 3 included cognitive test outcomes only. Receiver operating characteristics (ROC) and area under the curve (AUC) allowed evaluating discriminative performance of the three different models using independent validation data.

Results

Using N = 188 complete data sets of a total of 225 included cases, AIC identified age (p < 0.0008) and MMST (p = 0.024) as dominating predictors for MSDT outcomes with a median AUC of 0.71 (95%-CI 0.57–0.85) across different training and validation splits, while using the four cognitive test results exclusively yielded a median AUC of 0.55 (95%-CI 0.40–0.71).

Conclusions

Our analysis provided strong evidence for age as the single most dominant predictor of MSDT outcomes. Adding MMST provides only weak additional predictive value for MSDT outcomes. Combining the results of four cognitive test used as standard screen in Swiss traffic medicine alone, proved to be of poor predictive value. This highlights the importance of MSDTs for balancing between the mitigation of risks by and the right to drive for the elderly.
Literature
2.
go back to reference Grace J, Amick MM, D’abreu A, Festa EK, Heindel WC, Ott BR. Neuropsychological deficits associated with driving performance in Parkinson’s and Alzheimer’s disease. J Int Neuropsychol Soc. 2005;11(6):766–75.PubMedPubMedCentralCrossRef Grace J, Amick MM, D’abreu A, Festa EK, Heindel WC, Ott BR. Neuropsychological deficits associated with driving performance in Parkinson’s and Alzheimer’s disease. J Int Neuropsychol Soc. 2005;11(6):766–75.PubMedPubMedCentralCrossRef
3.
go back to reference Brown LB, Ott BR, Papandonatos GD, Sui Y, Ready RE, Morris JC. Prediction of on-road driving performance in patients with early Alzheimer’s disease. J Am Geriatr Soc. 2005;53(1):94–8.PubMedPubMedCentralCrossRef Brown LB, Ott BR, Papandonatos GD, Sui Y, Ready RE, Morris JC. Prediction of on-road driving performance in patients with early Alzheimer’s disease. J Am Geriatr Soc. 2005;53(1):94–8.PubMedPubMedCentralCrossRef
4.
go back to reference Ott BR, Anthony D, Papandonatos GD, D’Abreu A, Burock J, Curtin A, et al. Clinician assessment of the driving competence of patients with dementia. J Am Geriatr Soc. 2005;53(5):829–33.PubMedPubMedCentralCrossRef Ott BR, Anthony D, Papandonatos GD, D’Abreu A, Burock J, Curtin A, et al. Clinician assessment of the driving competence of patients with dementia. J Am Geriatr Soc. 2005;53(5):829–33.PubMedPubMedCentralCrossRef
8.
go back to reference Mosimann U, Bächli-Biétry J, Boll J, Bopp-Kistler I, Donati F, Kressig R, et al. Konsensusempfehlungen zur Beurteilung der medizinischen Mindestanforderungen für Fahreignung bei kognitiver Beeinträchtigung. Praxis. 2012;101(7):451–64.PubMedCrossRef Mosimann U, Bächli-Biétry J, Boll J, Bopp-Kistler I, Donati F, Kressig R, et al. Konsensusempfehlungen zur Beurteilung der medizinischen Mindestanforderungen für Fahreignung bei kognitiver Beeinträchtigung. Praxis. 2012;101(7):451–64.PubMedCrossRef
9.
go back to reference Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.PubMedCrossRef Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.PubMedCrossRef
10.
go back to reference Shulman KI, Pushkar Gold D, Cohen CA, Zucchero CA. Clock-drawing and dementia in the community: a longitudinal study. Int J Geriatr Psychiatry. 1993;8(6):487–96.CrossRef Shulman KI, Pushkar Gold D, Cohen CA, Zucchero CA. Clock-drawing and dementia in the community: a longitudinal study. Int J Geriatr Psychiatry. 1993;8(6):487–96.CrossRef
11.
go back to reference Reitan RM. Validity of the Trail Making Test as an Indicator of Organic Brain Damage. Percept Mot Skills. 1958;8(3):271–6.CrossRef Reitan RM. Validity of the Trail Making Test as an Indicator of Organic Brain Damage. Percept Mot Skills. 1958;8(3):271–6.CrossRef
12.
go back to reference Bowie CR, Harvey PD. Administration and interpretation of the Trail Making Test. Nat Protoc. 2006;1(5):2277–81.PubMedCrossRef Bowie CR, Harvey PD. Administration and interpretation of the Trail Making Test. Nat Protoc. 2006;1(5):2277–81.PubMedCrossRef
13.
go back to reference Iverson DJ, Gronseth GS, Reger MA, Classen S, Dubinsky RM, Rizzo M, et al. Practice parameter update: evaluation and management of driving risk in dementia: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74(16):1316–24.PubMedPubMedCentralCrossRef Iverson DJ, Gronseth GS, Reger MA, Classen S, Dubinsky RM, Rizzo M, et al. Practice parameter update: evaluation and management of driving risk in dementia: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74(16):1316–24.PubMedPubMedCentralCrossRef
14.
go back to reference Creavin ST, Wisniewski S, Noel‐Storr AH, Trevelyan CM, Hampton T, Rayment D, et al. Mini‐Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database Syst Rev. 2016;1(1):1–156. Creavin ST, Wisniewski S, Noel‐Storr AH, Trevelyan CM, Hampton T, Rayment D, et al. Mini‐Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database Syst Rev. 2016;1(1):1–156.
15.
go back to reference Ploenes C, Sharp S, Martin M. The Clock Test: drawing a clock for detection of cognitive disorders in geriatric patients. Z Gerontol. 1994;27(4):246–52.PubMed Ploenes C, Sharp S, Martin M. The Clock Test: drawing a clock for detection of cognitive disorders in geriatric patients. Z Gerontol. 1994;27(4):246–52.PubMed
16.
go back to reference Agrell B, Dehlin O. The clock-drawing test. Age Ageing. 1998;27(3):399–404.CrossRef Agrell B, Dehlin O. The clock-drawing test. Age Ageing. 1998;27(3):399–404.CrossRef
17.
go back to reference Tombaugh TN. Trail Making Test A and B: Normative data stratified by age and education. Arch Clin Neuropsychol. 2004;19(2):203–14.PubMedCrossRef Tombaugh TN. Trail Making Test A and B: Normative data stratified by age and education. Arch Clin Neuropsychol. 2004;19(2):203–14.PubMedCrossRef
18.
go back to reference Seeger R. Fahreignung bei kognitiven Einschränkungen. Die möglichst freiwillige Abgabe des Führerausweises ist das Ziel. Hausarzt Praxis. 2010:6 Seeger R. Fahreignung bei kognitiven Einschränkungen. Die möglichst freiwillige Abgabe des Führerausweises ist das Ziel. Hausarzt Praxis. 2010:6
20.
go back to reference Streiner DL, Cairney J. What’s under the ROC? An Introduction to Receiver Operating Characteristics Curves. The Canadian Journal of Psychiatry. 2007;52(2):121–8.PubMedCrossRef Streiner DL, Cairney J. What’s under the ROC? An Introduction to Receiver Operating Characteristics Curves. The Canadian Journal of Psychiatry. 2007;52(2):121–8.PubMedCrossRef
21.
go back to reference Adler G, Rottunda S, Dysken M. The older driver with dementia: An updated literature review. J Safety Res. 2005;36(4):399–407.PubMedCrossRef Adler G, Rottunda S, Dysken M. The older driver with dementia: An updated literature review. J Safety Res. 2005;36(4):399–407.PubMedCrossRef
22.
go back to reference Reger MA, Welsh RK, Watson GS, Cholerton B, Baker LD, Craft S. The Relationship between Neuropsychological Functioning and Driving Ability in Dementia: A Meta-Analysis. Neuropsychology. 2004;18(1):85–93.PubMedCrossRef Reger MA, Welsh RK, Watson GS, Cholerton B, Baker LD, Craft S. The Relationship between Neuropsychological Functioning and Driving Ability in Dementia: A Meta-Analysis. Neuropsychology. 2004;18(1):85–93.PubMedCrossRef
23.
go back to reference Mathias JL, Lucas LK. Cognitive predictors of unsafe driving in older drivers: a meta-analysis. Int Psychogeriatr. 2009;21(4):637–53.PubMedCrossRef Mathias JL, Lucas LK. Cognitive predictors of unsafe driving in older drivers: a meta-analysis. Int Psychogeriatr. 2009;21(4):637–53.PubMedCrossRef
24.
go back to reference Galski T, Bruno RL, Ehle HT. Driving after cerebral damage: a model with implications for evaluation. Am J Occup Ther. 1992;46(4):324–32.PubMedCrossRef Galski T, Bruno RL, Ehle HT. Driving after cerebral damage: a model with implications for evaluation. Am J Occup Ther. 1992;46(4):324–32.PubMedCrossRef
25.
go back to reference Stav WB, Justiss MD, McCarthy DP, Mann WC, Lanford DN. Predictability of clinical assessments for driving performance. J Safety Res. 2008;39(1):1–7.PubMedCrossRef Stav WB, Justiss MD, McCarthy DP, Mann WC, Lanford DN. Predictability of clinical assessments for driving performance. J Safety Res. 2008;39(1):1–7.PubMedCrossRef
26.
go back to reference Schulz P, Beblo T, Spannhorst S, Boedeker S, Kreisel SH, Driessen M, et al. Assessing fitness to drive in older adults: Validation and extension of an economical screening tool. Accid Anal Prev. 2021;149:105874.PubMedCrossRef Schulz P, Beblo T, Spannhorst S, Boedeker S, Kreisel SH, Driessen M, et al. Assessing fitness to drive in older adults: Validation and extension of an economical screening tool. Accid Anal Prev. 2021;149:105874.PubMedCrossRef
27.
go back to reference Toepper M, Schulz P, Beblo T, Driessen M. Predicting On-Road Driving Skills, Fitness to Drive, and Prospective Accident Risk in Older Drivers and Drivers with Mild Cognitive Impairment: The Importance of Non-Cognitive Risk Factors. J Alzheimers Dis. 2021;79(1):401–14.PubMedPubMedCentralCrossRef Toepper M, Schulz P, Beblo T, Driessen M. Predicting On-Road Driving Skills, Fitness to Drive, and Prospective Accident Risk in Older Drivers and Drivers with Mild Cognitive Impairment: The Importance of Non-Cognitive Risk Factors. J Alzheimers Dis. 2021;79(1):401–14.PubMedPubMedCentralCrossRef
28.
go back to reference O’Connor MG, Duncanson H, Hollis AM. Use of the MMSE in the Prediction of Driving Fitness: Relevance of Specific Subtests. J Am Geriatr Soc. 2019;67(4):790–3.PubMedCrossRef O’Connor MG, Duncanson H, Hollis AM. Use of the MMSE in the Prediction of Driving Fitness: Relevance of Specific Subtests. J Am Geriatr Soc. 2019;67(4):790–3.PubMedCrossRef
29.
go back to reference Dickerson AE, Meuel DB, Ridenour CD, Cooper K. Assessment tools predicting fitness to drive in older adults: a systematic review. Am J Occup Ther. 2014;68(6):670–80.PubMedCrossRef Dickerson AE, Meuel DB, Ridenour CD, Cooper K. Assessment tools predicting fitness to drive in older adults: a systematic review. Am J Occup Ther. 2014;68(6):670–80.PubMedCrossRef
30.
go back to reference Anstey KJ, Horswill MS, Wood JM, Hatherly C. The role of cognitive and visual abilities as predictors in the Multifactorial Model of Driving Safety. Accid Anal Prev. 2012;45:766–74.PubMedCrossRef Anstey KJ, Horswill MS, Wood JM, Hatherly C. The role of cognitive and visual abilities as predictors in the Multifactorial Model of Driving Safety. Accid Anal Prev. 2012;45:766–74.PubMedCrossRef
31.
go back to reference Ball KK, Roenker DL, Wadley VG, Edwards JD, Roth DL, McGwin G Jr, et al. Can High-Risk Older Drivers Be Identified Through Performance-Based Measures in a Department of Motor Vehicles Setting? J Am Geriatr Soc. 2006;54(1):77–84.PubMedCrossRef Ball KK, Roenker DL, Wadley VG, Edwards JD, Roth DL, McGwin G Jr, et al. Can High-Risk Older Drivers Be Identified Through Performance-Based Measures in a Department of Motor Vehicles Setting? J Am Geriatr Soc. 2006;54(1):77–84.PubMedCrossRef
32.
go back to reference Matas NA, Nettelbeck T, Burns NR. Cognitive and visual predictors of UFOV performance in older adults. Accid Anal Prev. 2014;70:74–83.PubMedCrossRef Matas NA, Nettelbeck T, Burns NR. Cognitive and visual predictors of UFOV performance in older adults. Accid Anal Prev. 2014;70:74–83.PubMedCrossRef
33.
go back to reference Anstey KJ, Eramudugolla R, Huque MH, Horswill M, Kiely K, Black A, et al. Validation of Brief Screening Tools to Identify Impaired Driving Among Older Adults in Australia. JAMA Network Open. 2020;3(6):e208263.PubMedPubMedCentralCrossRef Anstey KJ, Eramudugolla R, Huque MH, Horswill M, Kiely K, Black A, et al. Validation of Brief Screening Tools to Identify Impaired Driving Among Older Adults in Australia. JAMA Network Open. 2020;3(6):e208263.PubMedPubMedCentralCrossRef
34.
go back to reference Marottoli RA, Richardson ED, Stowe MH, Miller EG, Brass LM, Cooney LM Jr, et al. Development of a Test Battery to Identify Older Drivers at Risk for Self-Reported Adverse Driving Events. J Am Geriatr Soc. 1998;46(5):562–8.PubMedCrossRef Marottoli RA, Richardson ED, Stowe MH, Miller EG, Brass LM, Cooney LM Jr, et al. Development of a Test Battery to Identify Older Drivers at Risk for Self-Reported Adverse Driving Events. J Am Geriatr Soc. 1998;46(5):562–8.PubMedCrossRef
35.
go back to reference Stutts JC, Stewart JR, Martell C. Cognitive test performance and crash risk in an older driver population. Accid Anal Prev. 1998;30(3):337–46.PubMedCrossRef Stutts JC, Stewart JR, Martell C. Cognitive test performance and crash risk in an older driver population. Accid Anal Prev. 1998;30(3):337–46.PubMedCrossRef
36.
go back to reference Odenheimer GL, Beaudet M, Jette AM, Albert MS, Grande L, Minaker KL. Performance-Based Driving Evaluation of the Elderly Driver: Safety, Reliability, and Validity. J Gerontol. 1994;49(4):M153–9.PubMedCrossRef Odenheimer GL, Beaudet M, Jette AM, Albert MS, Grande L, Minaker KL. Performance-Based Driving Evaluation of the Elderly Driver: Safety, Reliability, and Validity. J Gerontol. 1994;49(4):M153–9.PubMedCrossRef
37.
go back to reference Fox GK, Bowden SC, Bashford GM, Smith DS. Alzheimer’s Disease and Driving: Prediction and Assessment of Driving Performance. J Am Geriatr Soc. 1997;45(8):949–53.PubMedCrossRef Fox GK, Bowden SC, Bashford GM, Smith DS. Alzheimer’s Disease and Driving: Prediction and Assessment of Driving Performance. J Am Geriatr Soc. 1997;45(8):949–53.PubMedCrossRef
38.
go back to reference Ferreira IS, Simões MR, Marôco J. The Addenbrooke’s Cognitive Examination Revised as a potential screening test for elderly drivers. Accid Anal Prev. 2012;49:278–86.PubMedCrossRef Ferreira IS, Simões MR, Marôco J. The Addenbrooke’s Cognitive Examination Revised as a potential screening test for elderly drivers. Accid Anal Prev. 2012;49:278–86.PubMedCrossRef
39.
go back to reference Margolis KL, Kerani RP, McGovern P, Songer T, Cauley JA, Ensrud KE. Risk factors for motor vehicle crashes in older women. Journals of Gerontology - Series A Biological Sciences and Medical Sciences. 2002;57(3):M186–91.CrossRef Margolis KL, Kerani RP, McGovern P, Songer T, Cauley JA, Ensrud KE. Risk factors for motor vehicle crashes in older women. Journals of Gerontology - Series A Biological Sciences and Medical Sciences. 2002;57(3):M186–91.CrossRef
40.
go back to reference Crizzle AM, Classen S, Bédard M, Lanford D, Winter S. MMSE as a predictor of on-road driving performance in community dwelling older drivers. Accid Anal Prev. 2012;49:287–92.PubMedCrossRef Crizzle AM, Classen S, Bédard M, Lanford D, Winter S. MMSE as a predictor of on-road driving performance in community dwelling older drivers. Accid Anal Prev. 2012;49:287–92.PubMedCrossRef
41.
go back to reference Wood JM, Horswill MS, Lacherez PF, Anstey KJ. Evaluation of screening tests for predicting older driver performance and safety assessed by an on-road test. Accid Anal Prev. 2013;50:1161–8.PubMedCrossRef Wood JM, Horswill MS, Lacherez PF, Anstey KJ. Evaluation of screening tests for predicting older driver performance and safety assessed by an on-road test. Accid Anal Prev. 2013;50:1161–8.PubMedCrossRef
42.
go back to reference Joseph PG, O’Donnell MJ, Teo KK, Gao P, Anderson C, Probstfield JL, et al. The mini-mental state examination, clinical factors, and motor vehicle crash risk. J Am Geriatr Soc. 2014;62(8):1419–26.PubMedCrossRef Joseph PG, O’Donnell MJ, Teo KK, Gao P, Anderson C, Probstfield JL, et al. The mini-mental state examination, clinical factors, and motor vehicle crash risk. J Am Geriatr Soc. 2014;62(8):1419–26.PubMedCrossRef
43.
go back to reference Lincoln NB, Taylor JL, Vella K, Bouman WP, Radford KA. A prospective study of cognitive tests to predict performance on a standardised road test in people with dementia. Int J Geriatr Psychiatry. 2010;25(5):489–96.PubMedCrossRef Lincoln NB, Taylor JL, Vella K, Bouman WP, Radford KA. A prospective study of cognitive tests to predict performance on a standardised road test in people with dementia. Int J Geriatr Psychiatry. 2010;25(5):489–96.PubMedCrossRef
44.
go back to reference Toepper M, Spannhorst S, Beblo T, Driessen M, Schulz P. SAFE-R. Z Neuropsychol. 2021;32(3):113–28.CrossRef Toepper M, Spannhorst S, Beblo T, Driessen M, Schulz P. SAFE-R. Z Neuropsychol. 2021;32(3):113–28.CrossRef
45.
go back to reference Mazer B, Chen Y-T, Vrkljan B, Marshall SC, Charlton JL, Koppel S, et al. Comparison of older and middle-aged drivers’ driving performance in a naturalistic setting. Accident Analysis & Prevention. 2021;161:106343.CrossRef Mazer B, Chen Y-T, Vrkljan B, Marshall SC, Charlton JL, Koppel S, et al. Comparison of older and middle-aged drivers’ driving performance in a naturalistic setting. Accident Analysis & Prevention. 2021;161:106343.CrossRef
46.
go back to reference Jakobsen JC, Gluud C, Wetterslev J, Winkel P. When and how should multiple imputation be used for handling missing data in randomised clinical trials – a practical guide with flowcharts. BMC Med Res Methodol. 2017;17(1):162.PubMedPubMedCentralCrossRef Jakobsen JC, Gluud C, Wetterslev J, Winkel P. When and how should multiple imputation be used for handling missing data in randomised clinical trials – a practical guide with flowcharts. BMC Med Res Methodol. 2017;17(1):162.PubMedPubMedCentralCrossRef
47.
go back to reference Sterne JAC, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.PubMedPubMedCentralCrossRef Sterne JAC, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.PubMedPubMedCentralCrossRef
48.
go back to reference Chawla NV, Bowyer KW, Hall LO, Kegelmeyer WP. SMOTE: synthetic minority over-sampling technique. Journal of artificial intelligence research. 2002;16:321–57.CrossRef Chawla NV, Bowyer KW, Hall LO, Kegelmeyer WP. SMOTE: synthetic minority over-sampling technique. Journal of artificial intelligence research. 2002;16:321–57.CrossRef
49.
go back to reference Kaussner Y, Kuraszkiewicz AM, Schoch S, Markel P, Hoffmann S, Baur-Streubel R, et al. Treating patients with driving phobia by virtual reality exposure therapy - a pilot study. PLoS One. 2020;15(1):e0226937.PubMedPubMedCentralCrossRef Kaussner Y, Kuraszkiewicz AM, Schoch S, Markel P, Hoffmann S, Baur-Streubel R, et al. Treating patients with driving phobia by virtual reality exposure therapy - a pilot study. PLoS One. 2020;15(1):e0226937.PubMedPubMedCentralCrossRef
50.
go back to reference Kenntner-Mabiala R, Kaussner Y, Jagiellowicz-Kaufmann M, Hoffmann S, Kruger HP. Driving performance under alcohol in simulated representative driving tasks: an alcohol calibration study for impairments related to medicinal drugs. J Clin Psychopharmacol. 2015;35(2):134–42.PubMedPubMedCentralCrossRef Kenntner-Mabiala R, Kaussner Y, Jagiellowicz-Kaufmann M, Hoffmann S, Kruger HP. Driving performance under alcohol in simulated representative driving tasks: an alcohol calibration study for impairments related to medicinal drugs. J Clin Psychopharmacol. 2015;35(2):134–42.PubMedPubMedCentralCrossRef
Metadata
Title
Strong evidence for age as the single most dominant predictor of medically supervised driving test—mini mental status test outcomes provide only weak but significant moderate additional predictive value
Authors
Yannik Isler
Simon Schwab
Regula Wick
Stefan Lakämper
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2022
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-022-02951-6

Other articles of this Issue 1/2022

BMC Geriatrics 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine